COVID-19 Is Back! The JN.1 variant is spreading rapidly across Asia: How COVID vaccines have prevented the past variants and ...

The DNA is basically a book of recipes. Each recipe tells the cells in our bodies how to make specific proteins by combining ...

Immunologists from the Institute have been the first to uncover a role for a family of RNA binding proteins in the function ...

Biomedical engineers at Georgia Tech created a treatment that could one day unlock a universal strategy for treating some of ...

To understand the mechanism of the nasal vaccines, the researchers first injected mice with a traditional mRNA COVID-19 shot, ...

In arm 1 of the trial, the dose-escalation portion, patients will receive mRNA-4106 at a test dose as monotherapy. In arm 2, ...

Breakthrough approval highlights the power of AIM’s next-gen platform and global ambition in biotech innovation.

While global giants like Moderna and BioNTech apply mRNA technology to broader disease markets, PRC's mRNA frontrunner is keeping pace. AIM Vaccine (06660.HK), a leading domestic vaccine company, ...

Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...

“Tregs play an important role in fundamental aspects of controlling the immune response. We found that the loss of these RNA ...

N of 1 therapy uniquely developed for infant with life-threatening rare metabolic disorder in six months by Aldevron and ...